51 results
425
EX-10.1
NTBL
Notable Labs Ltd
2 Oct 23
Business combination disclosure
5:31pm
, administrative authority, governmental department, agency, commission, bureau, official, minister, court, board, tribunal or body exercising executive, legislative
8-K
EX-10.1
NTBL
Notable Labs Ltd
2 Oct 23
Other Events
5:30pm
, administrative authority, governmental department, agency, commission, bureau, official, minister, court, board, tribunal or body exercising executive, legislative
424B3
NTBL
Notable Labs Ltd
2 Oct 23
Prospectus supplement
5:29pm
Entity” means any Israeli or any authorized state, provincial or local or municipal government, administrative authority, governmental department
424B3
2obbl4t oh7c
5 Sep 23
Prospectus supplement
6:02pm
S-4/A
kxecdor5 jz9
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
EX-10.9
f3uq7ncn8u0z 44paz
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
llaepj0
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.11
bwqaxtc apak
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.3
r9q9a3hx7xz
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.2
xqr1vkcrxfjwyb3caih
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
kciwxyj3cgexmhls
1 Sep 22
VBL Therapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
5:16pm
6-K
EX-99.2
nn3rdw3475s
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
6-K
EX-1.1
cibaht2ihi9lpxapy5
11 Feb 22
Current report (foreign)
5:29pm